TOP STORIES

• REGULATORY Generic Makers Flock to Samsca’s Heart Failure Market after Patent Invalidated; Gx Listing Expected in December
  August 16, 2022

• REGULATORY Authorized Generics Approved for Nexium, Samsca, Lipitor, Careram
  August 16, 2022

• REGULATORY First Generics for 5 APIs Approved towards December Listing, with 8 Firms for Nexium
  August 16, 2022

• REGULATORY Lilly’s GIP/GLP-1 Receptor Agonist Up for PAFSC Review on August 25
  August 15, 2022

• REGULATORY 26 Suspected Violations in Detailing Activities Reported in FY2021: MHLW
  August 12, 2022

• BUSINESS Sumitomo Pharma to Rev Up R&D for Regenerative Medicine, CNS towards Later 2030s
  August 12, 2022

• REGULATORY Chuikyo OKs Lagevrio, Voxzogo, Enjaymo, and More for August Listing, BioMarin Med with Biggest Peak Sales Outlook
  August 10, 2022

• REGULATORY Rybelsus Faces 2.5-2.6% Price Cut in November under CEA Scheme; No Change for Cabometyx
  August 10, 2022

• BUSINESS Sumitomo Drops 100 Billion Yen Diabetes Sales Goal as Trulicity Collab Ends
  August 10, 2022

• BUSINESS Yen’s Fall Reaps 10 Billion Yen-Plus Gain on Sales for 5 Japan Makers, Takeda Gets 8.8 Billion Yen: April-June
  August 9, 2022

• BUSINESS Pfizer Seeks Japan Nod for Omicron-Adapted Bivalent Jab
  August 9, 2022

• BUSINESS Single-Wholesaler Distribution Unlikely to Constitute Antimonopoly Law Violation: Expert
  August 8, 2022

• REGULATORY LDP Project Team to Make Proposals for Japan-Moderna Deal
  August 8, 2022

• BUSINESS Moderna Eyes mRNA Plant in Japan, but Multi-Year Purchase Pact a Must: Local President
  August 5, 2022

• ORGANIZATION Single-Wholesaler Distribution Should Be Redressed from Stable Supply Standpoint: JMA Official
  August 4, 2022

• BUSINESS Trulicity Sales Alliance Deal to Expire by 2022-End: Lilly Japan/Sumitomo
  August 4, 2022

• BUSINESS Mitsubishi to Review Biz Plan around Medicago’s COVID Jab, Reexamine Japan Timeline Too
  August 4, 2022

• REGULATORY Chuikyo Will Consider Any Proposals of New Panel on Drug Pricing: Pharma Management Director
  August 3, 2022

• REGULATORY Japan Approves KM Biologics’ Smallpox Vaccine for Monkeypox
  August 2, 2022

• BUSINESS Shionogi Eyes PIII Topline Readout for COVID Pill in Aug-Sept., Sticks to H1 Approval Plan
  August 2, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 67
• 68
• 69
• 70
• 71
• 72
• 73
• 74
• 75
• …
• Next ›
• 最終 »